These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 34900527)

  • 21. Therapeutic Agents in Alzheimer's Disease Through a Multi-targetdirected Ligands Strategy: Recent Progress Based on Tacrine Core.
    Lin H; Li Q; Gu K; Zhu J; Jiang X; Chen Y; Sun H
    Curr Top Med Chem; 2017; 17(27):3000-3016. PubMed ID: 28714419
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Developing a Semi-Supervised Approach Using a PU-Learning-Based Data Augmentation Strategy for Multitarget Drug Discovery.
    Hao Y; Li B; Huang D; Wu S; Wang T; Fu L; Liu X
    Int J Mol Sci; 2024 Jul; 25(15):. PubMed ID: 39125808
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Multi-Target Directed Drugs as a Modern Approach for Drug Design Towards Alzheimer's Disease: An Update.
    de Freitas Silva M; Dias KST; Gontijo VS; Ortiz CJC; Viegas C
    Curr Med Chem; 2018; 25(29):3491-3525. PubMed ID: 29332563
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Resveratrol-Based MTDLs to Stimulate Defensive and Regenerative Pathways and Block Early Events in Neurodegenerative Cascades.
    Herrera-Arozamena C; Estrada-Valencia M; López-Caballero P; Pérez C; Morales-García JA; Pérez-Castillo A; Sastre ED; Fernández-Mendívil C; Duarte P; Michalska P; Lombardía J; Senar S; León R; López MG; Rodríguez-Franco MI
    J Med Chem; 2022 Mar; 65(6):4727-4751. PubMed ID: 35245051
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Applications of Multi-Target Computer-Aided Methodologies in Molecular Design of CNS Drugs.
    Raevsky OA; Mukhametov A; Grigorev VY; Ustyugov A; Tsay SC; Jih-Ru Hwu R; Yarla NS; Tarasov VV; Aliev G; Bachurin SO
    Curr Med Chem; 2018; 25(39):5293-5314. PubMed ID: 28933295
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Seven Year Itch: Pan-Assay Interference Compounds (PAINS) in 2017-Utility and Limitations.
    Baell JB; Nissink JWM
    ACS Chem Biol; 2018 Jan; 13(1):36-44. PubMed ID: 29202222
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Targeting HIV/HCV Coinfection Using a Machine Learning-Based Multiple Quantitative Structure-Activity Relationships (Multiple QSAR) Method.
    Wei Y; Li W; Du T; Hong Z; Lin J
    Int J Mol Sci; 2019 Jul; 20(14):. PubMed ID: 31336592
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Virtual screening and molecular dynamics simulation approach for the identification of potential multi-target directed ligands for the treatment of Alzheimer's disease.
    Jangid K; Devi B; Sahoo A; Kumar V; Dwivedi AR; Thareja S; Kumar R; Kumar V
    J Biomol Struct Dyn; 2024; 42(1):509-527. PubMed ID: 37114423
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Navigating the Chemical Space of Multitarget-Directed Ligands: From Hybrids to Fragments in Alzheimer's Disease.
    Prati F; Cavalli A; Bolognesi ML
    Molecules; 2016 Apr; 21(4):466. PubMed ID: 27070562
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Rational Design of Multitarget-Directed Ligands: Strategies and Emerging Paradigms.
    Zhou J; Jiang X; He S; Jiang H; Feng F; Liu W; Qu W; Sun H
    J Med Chem; 2019 Oct; 62(20):8881-8914. PubMed ID: 31082225
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Bacterial Cytological Profiling Identifies Rhodanine-Containing PAINS Analogs as Specific Inhibitors of
    Montaño ET; Nideffer JF; Sugie J; Enustun E; Shapiro AB; Tsunemoto H; Derman AI; Pogliano K; Pogliano J
    J Bacteriol; 2021 Sep; 203(19):e0010521. PubMed ID: 34280002
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Pain of high-throughput screening--pan assay interference compounds].
    Xie T; Du GH
    Yao Xue Xue Bao; 2015 Aug; 50(8):925-30. PubMed ID: 26668990
    [TBL] [Abstract][Full Text] [Related]  

  • 33. How to Triage PAINS-Full Research.
    Dahlin JL; Walters MA
    Assay Drug Dev Technol; 2016 Apr; 14(3):168-74. PubMed ID: 26496388
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of Linkers and Substitutions on Multitarget Directed Ligands for Alzheimer's Diseases: Emerging Paradigms and Strategies.
    Pravin N; Jozwiak K
    Int J Mol Sci; 2022 May; 23(11):. PubMed ID: 35682763
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Technological advances in high-throughput screening.
    Liu B; Li S; Hu J
    Am J Pharmacogenomics; 2004; 4(4):263-76. PubMed ID: 15287820
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Advancements in the development of multi-target directed ligands for the treatment of Alzheimer's disease.
    Kumar N; Kumar V; Anand P; Kumar V; Ranjan Dwivedi A; Kumar V
    Bioorg Med Chem; 2022 May; 61():116742. PubMed ID: 35398739
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Rational drug design strategies for the development of promising multi-target directed indole hybrids as Anti-Alzheimer agents.
    George N; Jawaid Akhtar M; Al Balushi KA; Alam Khan S
    Bioorg Chem; 2022 Oct; 127():105941. PubMed ID: 35714473
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Multifunctional ligands--a new approach in the search for drugs against multi-factorial diseases].
    Wichur T; Malawska B
    Postepy Hig Med Dosw (Online); 2015 Jan; 69():1423-34. PubMed ID: 27259214
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Chemical Characterization,
    Ansari JA; Ahmad MK; Fatima N; Azad I; Mahdi AA; Satyanarayan GNV; Ahmad N
    Anticancer Agents Med Chem; 2022; 22(20):3416-3437. PubMed ID: 35125087
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Locating sweet spots for screening hits and evaluating pan-assay interference filters from the performance analysis of two lead-like libraries.
    Mok NY; Maxe S; Brenk R
    J Chem Inf Model; 2013 Mar; 53(3):534-44. PubMed ID: 23451880
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.